The annual tick report shows Lone Star ticks have established populations along Connecticut's shoreline, raising the risk of ...
The first human Lyme disease vaccine was 73% effective against the tick-borne illness, says Pfizer. They still plan to seek ...
In March 2026, Pfizer and partner Valneva reported that their investigational 6‑valent OspA-based Lyme disease vaccine ...
If approved, the Pfizer-Valneva vaccine could become highly sought-after as Lyme disease surges in the Hudson Valley.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results